Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Alden

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
European Journal of Medicinal Chemistry|November 26, 2025
Second generation repurposing of phenothiazine antipsychotic drugs as antifungal lead molecules via optimization of phenoxazine derivativesSoumitra Guin, Kathryn M Alden, Emily Harshbarger, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|December 29, 2000
Specific binding of IL-8 to rabbit alpha-macroglobulin modulates IL-8 function in the lungA Kurdowska, N Fujisawa, B Peterson, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 12, 2002
Activity of pulmonary edema fluid interleukin-8 bound to alpha(2)-macroglobulin in patients with acute lung injuryAnna K Kurdowska, Thomas K Geiser, Susanne M Alden, et al.
British Journal of Cancer|November 21, 1998
A phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusionL Paz-Ares, R Kunka, D DeMaria, et al.
ACS Omega|May 19, 2025
Antifungal Structure-Activity Relationship Studies of Broad-Spectrum PhenothiazinesSamantha C Brosend, Soumitra Guin, Gregory Giovine, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2025
Synthesis and evaluation of acyl-AMP phosphate isosteres as inhibitors of fungal acetyl CoA synthetaseDrashti G Daraji, Andrew J Jezewski, Katy M Alden, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 16, 2013
Clinical and biomarker outcomes of the phase II vandetanib study from the BATTLE trialAnne S Tsao, Suyu Liu, J Jack Lee, et al.
ACS Chemical Biology|August 9, 2021
Structural Characterization of the Reaction and Substrate Specificity Mechanisms of Pathogenic Fungal Acetyl-CoA SynthetasesAndrew J Jezewski, Katy M Alden, Taiwo E Esan, et al.
ACS Omega|May 4, 2026
Optimization of Antifungal 1,5-Diaryl-Pyrazole Acetyl-CoA Synthetase InhibitorsJonah P Propp, Jeffrey C Ferreira, Parisa Enayati, et al.
Research Square|January 13, 2025
Discovery and mechanism of a highly selective, antifungal acetyl CoA synthetase inhibitorAndrew J Jezewski, Katy M Alden, Drashti G Daraji, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
European Journal of Medicinal Chemistry|November 26, 2025
Second generation repurposing of phenothiazine antipsychotic drugs as antifungal lead molecules via optimization of phenoxazine derivativesSoumitra Guin, Kathryn M Alden, Emily Harshbarger, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|December 29, 2000
Specific binding of IL-8 to rabbit alpha-macroglobulin modulates IL-8 function in the lungA Kurdowska, N Fujisawa, B Peterson, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 12, 2002
Activity of pulmonary edema fluid interleukin-8 bound to alpha(2)-macroglobulin in patients with acute lung injuryAnna K Kurdowska, Thomas K Geiser, Susanne M Alden, et al.
British Journal of Cancer|November 21, 1998
A phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusionL Paz-Ares, R Kunka, D DeMaria, et al.
ACS Omega|May 19, 2025
Antifungal Structure-Activity Relationship Studies of Broad-Spectrum PhenothiazinesSamantha C Brosend, Soumitra Guin, Gregory Giovine, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2025
Synthesis and evaluation of acyl-AMP phosphate isosteres as inhibitors of fungal acetyl CoA synthetaseDrashti G Daraji, Andrew J Jezewski, Katy M Alden, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 16, 2013
Clinical and biomarker outcomes of the phase II vandetanib study from the BATTLE trialAnne S Tsao, Suyu Liu, J Jack Lee, et al.
ACS Chemical Biology|August 9, 2021
Structural Characterization of the Reaction and Substrate Specificity Mechanisms of Pathogenic Fungal Acetyl-CoA SynthetasesAndrew J Jezewski, Katy M Alden, Taiwo E Esan, et al.
ACS Omega|May 4, 2026
Optimization of Antifungal 1,5-Diaryl-Pyrazole Acetyl-CoA Synthetase InhibitorsJonah P Propp, Jeffrey C Ferreira, Parisa Enayati, et al.
Research Square|January 13, 2025
Discovery and mechanism of a highly selective, antifungal acetyl CoA synthetase inhibitorAndrew J Jezewski, Katy M Alden, Drashti G Daraji, et al.
Pageof 5